WINDTREE THERAPEUTICS INC /DE/ Foreign Currency Transaction Gain (Loss), Unrealized
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Foreign Currency Transaction Gain (Loss), Unrealized of -$580.00 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-19.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossUnrealized · last filed 2025-08-19
- 2025-06-30: Foreign Currency Transaction Gain (Loss), Unrealized 6 month -$580.00K.
- 2024-06-30: Foreign Currency Transaction Gain (Loss), Unrealized 6 month $300.00K.
| Period end | Foreign Currency Transaction Gain (Loss), Unrealized 6 month |
|---|---|
| 2025-06-30 | -$580.00K 10-Q · filed 2025-08-19 |
| 2024-06-30 | $300.00K 10-Q · filed 2025-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |